INTEGRATIVE ONCOLOGY

INTEGRATIVE ONCOLOGY

A new concept that combines the means of conventional medicine with those of complementary biological medicine, to achieve greater effectiveness on treatments, we use integrated compatible systems that optimize the outcome regarding prevention, cure, and health palliation, and promotes healthy habits for life.

Medicine is only one and that regardless of the field from which you are working, the priority is that each patient receives what is best for their recovery.

This helps side effects of conventional treatments, both physical and emotional decrease considerably, in parallel with a Detox Program with antioxidants and vitamins to promote the elimination of chemicals. Taking care and ensuring the proper functioning of the immune system, plus an adjustment in diet and emotional support are equally decisive for a complete integrated treatment. The key of Integrative Medicine is in the selection and application of therapies for each patient, and that they are carried out in an ethical, professional and human way, which will improve the quality of the medicine and the benefits for the patient.

Treatment Phases

Integrative oncology consists of four main phases:

Treatment Phases

1. Evaluation: Review of the medical history by the medical director, where information will be collected and, if necessary, some blood tests will be taken to know the current state of the patient’s health; these tests will give us information on the hemodynamic, metabolic and inflammatory aspects of the tissues. Additional studies will determine the current state of the immune system, such as tumor necrosis factor, circulating tumor cell count (CTC), regulatory T lymphocytes, glutathione, and sensitivity to the application of some natural medications that we could use for the benefit of the patient, such as vitamin C, amygdalin (Vit B 17), an Oncotype Dx would provide information on the sensitivity to certain chemotherapeutic drugs that we could use if necessary in low doses such as IPT (Insulin Potentiation Therapy). Likewise, a complete nutritional review and evaluation will be performed and an evaluation by Internal Medicine, if needed.

2. Conditioning: This phase is where nutritional deficiencies if any, are corrected by an assessment by critical medicine pain management (if needed), and processes of detox. Pre-activation of the immune system, drainage, decreased activation of blocking cells of the immune system, reduction of circulating tumor burden, improving oxidative stress. Different therapies like Chelation to remove heavy metals, Ozone to reduce inflammation and revitalize the tissues, as well as anti-oxidants like Vitamin C in mega doses to boost the effectiveness of other cancer treatments. During this phase may also be used (if necessary), the application of low doses of chemotherapy using insulin as a biological response modifier, which is known as Insulin Potentiation Targeted Low Dose therapy (IPTLD). It is an innovative system that enables cancer treatment using chemotherapy drugs selected according to the acceptance of the oncological practice. These drugs are administered in much lower doses than accepted as standard doses.

3. Activation of the Immune System: It is executed in combination with the laboratory of Immunology and hematology where all immunotherapy protocols are studied and prepared for each patient. This is carried out with the activation and proliferation of cells of the immune system that participate in the destruction of the tumors, these processes are performed “in vitro” and subsequently applied to the patient, the patient usually does not present side effects or events clinical rejection, since will be his “own cells”. This phase is the most important of the program since it is where the cellular immunotherapy is carried out, with dendritic cells, activated cytotoxic lymphocytes, natural killer lymphocyte and a cocktail of autologous cytokines that auto-activate the immune system.

4. Maintenance: In this phase, the patient continues activating his or her immune system in a targeted manner with autologous cytokines ( Leukocyte autologous or anti-cancer vaccines based on the type of cancer) and maintaining the balance of cell proliferation, with natural agents that demonstrated (“in vitro “) to have an effect on the destruction of circulating malignant cells.